Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors by Shaoyan Lin, Yuxiang Ma, Yongsheng Wang, Yunpeng Yang, Jinhui Xue, Yan Huang, Yuanyuan Zhao, Wenfeng Fang, Shaodong Hong, Yang Zhang, Qianwen Liu, Guizhong Liu, Xiaohong She, Jiping Zha, Songmao Zheng, Yan Li, Peter Luo, Li Zhang, Hongyun Zhao

Get full text